Forecast 2023
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
Forecast 2030
TopGraphs Quality Ranking
Underperform
Company Info
P/E
0.00
Beta
0.42
Price-to-book Ratio
3.06
Market Cap
3.19B
TEV
3.06 B
Dividend
¥0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥23.58
Industry
Country
Staidson (Beijing) BioPharmaceuticals Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Staidson (Beijing) BioPharmaceuticals Stock Forecast 2023
¥0.00
In the last five quarters, Staidson (Beijing) BioPharmaceuticals’s Price Target has risen from ¥23.58 to ¥23.58 - a 0% increase.
-100%
Last update: 05/14/2024
Highest Price Target ¥0.00
Average Price Target ¥0.00
Lowest Price Target ¥0.00
Staidson (Beijing) BioPharmaceuticals Stock Prediction 2025
Staidson (Beijing) BioPharmaceuticals Stock Forecast 2030
P/E
0.00
Beta
0.42
Price-to-book Ratio
3.06
Market Cap
3.19B
TEV
3.06 B
Dividend
¥0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥23.58
Industry
Country
Staidson (Beijing) BioPharmaceuticals Analyst Ratings Frequently Asked Questions
Who are the analysts watching Staidson (Beijing) BioPharmaceuticals Co., Ltd.?
The following analysts have recently covered Staidson (Beijing) BioPharmaceuticals:
Data Unavailable
(This information refers to the last 90 days.)
Who are the sell-side analysts watching Staidson (Beijing) BioPharmaceuticals Co., Ltd.?
The following sell-side analysts have recently covered Staidson (Beijing) BioPharmaceuticals:
Data Unavailable
(This information refers to the last 90 days.)